Philip W. Rouadi
Dr. Philip W. Rouadi was born in Tripoli, Lebanon in 1966. He is a medical doctor who graduated from the American University of Beirut, Lebanon in 1991. He completed his postgraduate studies at the American University of Beirut-Medical Center Beirut, where he graduated as an Otolaryngology-Head and Neck Surgery specialist in 1996.
He completed his Fellowship in Otolaryngology-Head and Neck surgery, Allergy and Rhinology (1996-1997) at the University Of Chicago Hospitals in Illinois, USA, where he also completed a Clinical Training in Sleep-Related Disorders at the Department of Neurology and Neurophysiology. He received advanced training in Endoscopic Sinus Surgery at the John Hopkins Medical Institution Baltimore, Maryland, USA in 1997.
Currently, Dr Rouadi is an assistant professor of otolaryngology-Head and Neck surgery at the Eye and Ear University Hospital in Beirut, Lebanon; and also the director of the Allergy and Sleep Laboratories, and Head of ENT Residency Training Program at the same hospital. He is currently a surgical consultant at the Middle East Institute of Health- Cancer Center, and is a part time teaching professor at the “Holy Spirit University in Kaslik”, (Beirut) faculty of Medicine.
Dr Philip Rouadi has several publications in peer-reviewed journals and medical textbooks in the field of allergy and otolaryngology. He has chaired and co-chaired many national (Lebanese) and international congresses in the field of pollution, allergy and rhinology.
He is the immediate past President of the Lebanese Society of Allergy and Immunology and member of Lebanese Society of Otolaryngology- Head and Neck Surgery, and the European Academy of Allergy Asthma and Clinical Immunology, and the European Academy of Facial Plastic Surgery. He is the recipient of WAO Special Recognition Award (2019) and serves as co-chair of WAO the Rhinitis and Rhinosinusitis chapter in the same organization.
Dr Rouadi is on the Speaker’s bureau for GSK, MSD, Astra Zeneca, Bayer, Takeda, Novartis, Meda, Pharmaline, and Algorithm pharmaceuticals. He is also on the Speaker’s bureau and Congress Advisory Committee for Sanofi, and Abbott pharmaceuticals.
His areas of interest are pollution, allergy and immunotherapy, chronic rhinosinusitis, pharmacodynamics of intranasal steroids, skull base and olfactory cleft surgery, facial plastic and cosmetic surgery.